Exhibit 99.1

UNIVERSAL HEALTH REALTY INCOME TRUST		Universal Corporate Center
		367 S. Gulph Road
		P.O. Box 61558
		King of Prussia, PA 19406
		(610) 265-0688
FOR IMMEDIATE RELEASE
CONTACT:	Charles Boyle	October 27, 2025
	Chief Financial Officer
	(610) 768-3300

UNIVERSAL HEALTH REALTY INCOME TRUST

REPORTS FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH

PERIODS ENDED SEPTEMBER 30, 2025

Consolidated Results of Operations - Three-Month Periods Ended September 30, 2025 and 2024:

KING OF PRUSSIA, PA - Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended September 30, 2025, net income was $4.0 million, or $.29 per diluted share, as compared to $4.0 million, or $.29 per diluted share, during the third quarter of 2024.

Our net income during the third quarter of 2025, as compared to third quarter of 2024, included the following: (i) an increase of $275,000, or $.02 per diluted share, resulting from a one-time settlement and release agreement executed during the third quarter of 2025 in connection with one of our medical office buildings, and; (ii) an other combined net decrease of $256,000, or $.02 per diluted share, resulting primarily from a decrease in the net aggregate income generated at various properties, including approximately $900,000 of nonrecurring depreciation expense recorded during the third quarter of 2025.

As calculated on the attached Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”), our funds from operations ("FFO"), which excludes depreciation and amortization expense, increased by $908,000, or $.06 per diluted, share to $12.2 million, or $.88 per diluted share, during the third quarter of 2025, as compared to $11.3 million, or $.82 per diluted share, during the third quarter of 2024.

Consolidated Results of Operations - Nine-Month Periods Ended September 30, 2025 and 2024:

For the nine-month period ended September 30, 2025, net income was $13.3 million, or $.96 per diluted share, as compared to $14.6 million, or $1.05 per diluted share, during the comparable period of 2024.

The decrease in our net income of $1.3 million, or $.09 per diluted share, during the first nine months of 2025, as compared to the comparable period of 2024, consisted of the following: (i) a decrease of $730,000, or $.05 per diluted share, resulting from an aggregate net decrease in the income generated at various properties, including the above-mentioned nonrecurring depreciation expense of approximately $900,000 recorded during the third quarter of 2025; (ii) a decrease of $563,000, or $.04 per diluted share, related to a property tax reduction recorded during the first nine months of 2024 at our property located in Chicago, Illinois, (iii) an increase of $275,000, or $.02 per diluted share, resulting from the above-mentioned, one-time settlement and release agreement executed during the third quarter of 2025, and; (iv) a decrease of $282,000, or $.02 per diluted share, resulting from an increase in interest

expense due primarily to an increase in our average borrowings outstanding pursuant to our credit agreement.

As calculated on the attached Supplemental Schedule, our FFO, which excludes depreciation and amortization expense, decreased by $166,000, or $.02 per diluted share, to $35.9 million, or $2.59 per diluted share, during the first nine months of 2025, as compared to $36.1 million, or $2.61 per diluted share during the comparable period of 2024.

Dividend Information:

The third quarter dividend of $.74 per share, or $10.3 million in the aggregate, was declared on September 22, 2025 and paid on September 30, 2025.

Capital Resources Information:

As of September 30, 2025, pursuant the terms of our $425 million credit agreement which is scheduled to expire on September 30, 2028, we had $67.9 million of available borrowing capacity, net of $357.1 million of borrowings. We have the option to extend the credit agreement for up to two additional six-month periods.

Palm Beach Gardens Medical Plaza I:

In October 2025, we entered into a ground lease with a wholly-owned subsidiary of UHS with the intent to develop, construct and own the real property of Palm Beach Gardens Medical Plaza I, an 80,000 square foot medical office building ("MOB") located in Palm Beach Gardens, Florida. This MOB will be located on the campus of the Alan B. Miller Medical Center, a newly constructed acute care hospital owned and operated by a wholly-owned subsidiary of UHS, which is scheduled to be completed and opened during the third quarter of 2026.

Construction of this MOB, for which we have engaged a wholly-owned subsidiary of UHS to act as project manager, is expected to commence in November, 2025. The cost of the MOB is estimated to be approximately $34 million. A wholly-owned subsidiary of UHS has executed a 10-year master flex lease agreement, which is subject to reduction based on the execution of third-party leases, for approximately 75% of the rentable square feet of the MOB.

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human-service related facilities including acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments or commitments in seventy-seven properties located in twenty-one states.

This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7 - Forward-Looking Statements in our Form 10-K for the year ended December 31, 2024 and in Item 2 - Forward-Looking Statements and Certain Risk Factors in our Form 10-Q for the quarter ended June 30, 2025), may cause the results to differ materially from those anticipated in the forward-looking statements. Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Many of the factors that could affect our future results are beyond our control or ability to predict. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by various developments including, but not limited to, potential significant reductions in federal funding for state Medicaid programs, and/or other potential changes, which would likely result in reduced Medicaid payments to the operators of our facilities; decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the shortage of nurses and other clinical staff and support personnel; the impact of government and administrative regulation of the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential cost increases and disruptions related to supplies and building materials resulting from changes in laws or policies governing the terms of foreign trade, and in particular, increased trade restrictions, tariffs or taxes on imports from where the products or materials are made; and potential increases to other expenditures.

In addition, the increase in interest rates during the past few years has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms. Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.

We believe that, if and when applicable, adjusted net income and adjusted net income per diluted share (as reflected on the Supplemental Schedule), which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items that are non-recurring or non-operational in nature including items such as, but not limited to, gains or losses on transactions.

Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. FFO adjusts for the effects of certain items, such as gains or losses on transactions that occurred during the periods presented. FFO does not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders. A reconciliation of our reported net income to FFO is reflected on the Supplemental Schedules included below.

To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2024 and our Report on Form 10-Q for the quarter ended June 30, 2025. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented,

are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

(more)

Universal Health Realty Income Trust

Consolidated Statements of Income

For the Three and Nine Months Ended September 30, 2025 and 2024

(amounts in thousands, except share information)

(unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2025			2024			2025			2024
Revenues:
Lease revenue - UHS facilities (a.)	$	8,367		$	8,248		$	25,075		$	25,366
Lease revenue - Non-related parties		14,777			14,342			43,676			43,188
Other revenue - UHS facilities		233			242			699			682
Other revenue - Non-related parties		577			305			1,218			1,056
Interest income on financing leases - UHS facilities		1,348			1,357			4,050			4,077
		25,302			24,494			74,718			74,369
Expenses:
Depreciation and amortization		7,903			7,009			21,742			20,624
Advisory fees to UHS		1,414			1,386			4,169			4,093
Other operating expenses		7,591			7,609			22,535			22,115
		16,908			16,004			48,446			46,832
Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense		8,394			8,490			26,272			27,537
Equity in income of unconsolidated LLCs		438			300			1,215			956
Interest expense, net		(4,816	)		(4,793	)		(14,202	)		(13,920	)
Net income	$	4,016		$	3,997		$	13,285		$	14,573
Basic earnings per share	$	0.29		$	0.29		$	0.96		$	1.06
Diluted earnings per share	$	0.29		$	0.29		$	0.96		$	1.05
Weighted average number of shares outstanding - Basic		13,828			13,807			13,818			13,799
Weighted average number of shares outstanding - Diluted		13,874			13,849			13,860			13,835

(a.) Includes bonus rental on McAllen Medical Center, a UHS acute care hospital facility, of $895 and $765 for the three-month periods ended September 30, 2025 and 2024, respectively, and $2.6 million and $2.3 million for the nine-month periods ended September 30, 2025 and 2024, respectively.

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)

For the Three Months Ended September 30, 2025 and 2024

(amounts in thousands, except share information)

(unaudited)

Calculation of Funds From Operations (“FFO”)

	Three Months Ended				Three Months Ended
	September 30, 2025				September 30, 2024
	Amount		Per Diluted Share		Amount		Per Diluted Share
Net income	$	4,016	$	0.29	$	3,997	$	0.29
Plus: Depreciation and amortization expense:
Consolidated investments		7,903		0.57		7,009		0.51
Unconsolidated affiliates		306		0.02		311		0.02
FFO	$	12,225	$	0.88	$	11,317	$	0.82
Dividend paid per share			$	0.740			$	0.730

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)

For the Nine Months Ended September 30, 2025 and 2024

(amounts in thousands, except share information)

(unaudited)

Calculation of Funds From Operations (“FFO”)

	Nine Months Ended				Nine Months Ended
	September 30, 2025				September 30, 2024
	Amount		Per Diluted Share		Amount		Per Diluted Share
Net income	$	13,285	$	0.96	$	14,573	$	1.05
Plus: Depreciation and amortization expense:
Consolidated investments		21,742		1.57		20,624		1.49
Unconsolidated affiliates		922		0.06		918		0.07
FFO	$	35,949	$	2.59	$	36,115	$	2.61
Dividend paid per share			$	2.215			$	2.185

Universal Health Realty Income Trust

Consolidated Balance Sheets

(amounts in thousands, except share information)

(unaudited)

	September 30,			December 31,
	2025			2024
Assets:
Real Estate Investments:
Buildings and improvements and construction in progress	$	661,258		$	655,996
Accumulated depreciation		(306,553	)		(286,932	)
		354,705			369,064
Land		56,870			56,870
Net Real Estate Investments		411,575			425,934
Financing receivable from UHS		82,315			82,798
Net Real Estate Investments and Financing receivable		493,890			508,732
Investments in limited liability companies ("LLCs")		20,817			13,948
Other Assets:
Cash and cash equivalents		6,916			7,097
Lease and other receivables from UHS		6,985			7,131
Lease receivable - other		8,720			7,975
Intangible assets (net of accumulated amortization of $11.3 million during each period)		6,045			7,325
Right-of-use land assets, net		10,896			10,918
Deferred charges, notes receivable and other assets, net		13,768			17,736
Total Assets	$	568,037		$	580,862
Liabilities:
Line of credit borrowings	$	357,050		$	348,900
Mortgage notes payable, non-recourse to us, net		18,575			19,349
Accrued interest		885			694
Accrued expenses and other liabilities		11,230			10,444
Ground lease liabilities, net		10,896			10,918
Tenant reserves, deposits and deferred and prepaid rents		10,827			11,016
Total Liabilities		409,463			401,321
Equity:
Preferred shares of beneficial interest,    $.01 par value; 5,000,000 shares authorized;    none issued and outstanding		-			-
Common shares, $.01 par value;    95,000,000 shares authorized; issued and outstanding: 2025 - 13,873,583;    2024 - 13,849,424		139			138
Capital in excess of par value		271,833			271,092
Cumulative net income		858,580			845,295
Cumulative dividends		(974,107	)		(943,396	)
Accumulated other comprehensive income		2,129			6,412
Total Equity		158,574			179,541
Total Liabilities and Equity	$	568,037		$	580,862